Phase I and Pharmacological Study of the New Topoisomerase I Inhibitor GI147211, Using a Daily X 5 Intravenous Administration

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1996.130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC